This podcast episode provides a comprehensive review of recent regulatory developments impacting key sectors such as the Board of Supervisors, MiCA, Compensation Scheme, Infected Blood Compensation, and the Critical Medicines Act.

Among the major updates, the European Securities and Markets Authority (ESMA) outlined its supervisory priorities and regulatory simplification efforts during its July Board of Supervisors meeting, aiming to enhance convergence and address emerging risks in financial markets.

France’s Autorité des Marchés Financiers (AMF) revised its doctrine to require financial investment advisers to obtain authorization as crypto-asset services providers (CASPs) under MiCA to provide personalized crypto-asset advice, marking a significant regulatory shift.

Additionally, the European Union is advancing pharmaceutical legislation to tackle medicine shortages through new shortage prevention plans and vulnerability assessments, alongside an increase in France’s mandatory contribution for victims of terrorist acts under the compensation scheme.

For more information, visit the Carver Agents website.

Articles mentioned:

1. Understanding selection criteria for medical device application audits
2. Minutes - Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2026
3. Summary of Conclusions Board of Supervisors - July 2026
4. Bloomsbury Institute's student sponsor licence revoked
5. Nur 1,8 Prozent der Webseitenbetreiber nutzen security.txt – BSI und ACS raten zur Umsetzung
6. IBCA Community Update, 6 August 2026
7. Tribunal upholds FCA ban on pair involved in pension transfer advice and reduces fines
8. Augmentation de la contribution obligatoire pour les victimes d’actes terroristes
9. Advice on crypto-assets: the AMF updates its doctrine in relation to FIAs
10. Advice on crypto-assets: the AMF updates its doctrine in relation to FIAs